ETIKA BISNIS PERSAINGAN INDUSTRI PELAYANAN KESEHATAN
DOI:
https://doi.org/10.46306/bacmatech.v1i2.33Keywords:
Keywords: Industry, Supervision, Competition, Health ServicesAbstract
The COVID-19 pandemic and the Epidemiological Transition are the drivers of the development of an increasingly advanced health system. The revolution in the health service industry makes all health service industry operators compete with each other to compete for competitive advantages in the midst of Indonesia's potential health market. The urge to supervise competition in the health industry that is free from elements of crime is very important to ensure that in the environment of the health service industry there is no one disadvantaged. This study aims to analyze the phenomenon of competition in the health service industry in the clinic, hospital, health insurance, clinical pharmacy, medical device and traditional medicine industry in Indonesia from the perspective of business competition law and review the role of the Business Competition Supervisory Commission (ICC) in preventing monopolistic practices and unfair business competition in the health service subsector. The results of the study show that the competition in the health service industry is hidden but dangerous, namely cheating in the hands of patients, the health business mafia and the monopoly of companies that occupy the highest health business ratings. In addition, it was found that the fact of supervision of competition in the health service industry was very intriguing.Downloads
References
Hikmawati and R. Setiyabudi, “Epidemiology of COVID-19 in Indonesia: common source and propagated source as a cause for outbreaks,” J Infect Dev Ctries, vol. 15, no. 5, pp. 646–652, 2021
D. C. Pelupessy, Y. Jibiki, and D. Sasaki, “Exploring People’s Perception of COVID-19 Risk: A Case Study of Greater Jakarta, Indonesia,” Int J Environ Res Public Health, vol. 20, no. 1, p. 336, Dec. 2022
R. Diprose and M. N. Azca, “Conflictmanagement in Indonesia’s post- authoritarian democracy: resource contestation, power dynamics and brokerage,” Conflict, Security and Development, vol. 20, no. 1, pp. 191–221,
T. Siswati, B. A. Paramashanti, M. P. Rialihanto, and L. Waris, “Epidemiological Transition in Indonesia and Its Prevention: A Narrative Review,” Journal of Complementary and Alternative Medical Research, no. May, pp. 50–60
A. W. Widayanti, J. A. Green, S. Heydon, and P. Norris, “Health-Seeking Behavior of People in Indonesia: A Narrative Review,” J Epidemiol Glob Health, vol. 10
V. M. Oddo, A. Roshita, and J. H. Rah, “Potential interventions targeting adolescent nutrition in Indonesia: a literature review,” Public Health Nutr, vol. 22, no. 1, pp. 15–27, Jan. 2019
T. Marthias et al., “Impact of non- communicable disease multimorbidity on health service use, catastrophic health expenditure and productivity loss in Indonesia: A population-based panel data analysis study,”
T. Chairil, “Indonesian Government’s COVID-19 Measures, January–May 2020: Late Response and Public Health Securitization,” Jurnal Ilmu Sosial dan Ilmu Politik, vol. 24, no. 2, pp. 128–152, 2021
Y. Lan, A. Chandrasekaran, D. Goradia, and D. Walker, “Collaboration Structures in Integrated Healthcare Delivery Systems: An Exploratory Study of Accountable Care Organizations,” Manufacturing & Service Operations Management, vol. 24, no. 3, pp. 1796–1820, May 2022
B. Tukamuhabwa, H. Mutebi, and D. Isabirye, “Supplier performance in the public healthcare: internal social capital, logistics capabilities and supply chain risk management capabilities as antecedents in a developing economy,” Journal of Business and Socio-economic Development, 2021
T. Marthias et al., “Impact of non- communicable disease multimorbidity on health service use, catastrophic health expenditure and productivity loss in Indonesia: a population-based panel data analysis study,” BMJ Open, vol. 11, no. 2, p. e041870, Feb. 2021
C. Maharani, S. R. Rahayu, M. Marx, and S. Loukanova, “The National Health Insurance System of Indonesia and primary care physicians’ job satisfaction: a prospective qualitative study,” Fam Pract, vol. 39, no. 1, pp. 112–124, Jan. 2022
A. Fuady, T. A. J. Houweling, M. Mansyur, and J. H. Richardus, “Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia’s implementation of universal health coverage,” Infect Dis Poverty, vol. 7, no. 1
A. Fuady, T. A. J. Houweling, M. Mansyur,E. Burhan, and J. H. Richardus, “Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis- affected households in Indonesia: eight simulated scenarios,” Infect Dis Poverty, vol. 8, no. 1, p. 10
D. K. Sunjaya, D. M. D. Herawati, E. D. Sihaloho, D. Hardiawan, R. Relaksana, and A. Y. M. Siregar, “Factors Affecting Payment Compliance of the Indonesia National Health Insurance Participants,” Risk Manag Healthc Policy, vol. Volume 15, pp. 277–288, Feb. 2022
Y. Mahendradhata, “Proceed with caution: Potential challenges and risks of developing healthcare tourism in Indonesia,” Glob Public Health, vol. 14, no. 3, pp. 340–350, Mar. 2019
I. Efendy, M. Nyorong, A. Amirah, and F. Sari, “National Health Insurance (JKN) Mobile Application Use Towards Satisfaction of Participants of the Health Social Security Implementing Agency (BPJS) in Madani Hospital in Medan City,” Journal of Medical and Health Studies, vol. 3, no. 1, pp. 26–34, Jan. 2022
M. Apriani and H. Idris, “Farmers’ Intention to Apply for National Health Insurance,” Unnes Journal of Public Health, vol. 11, no. 2, 2022
D. Erlangga, S. Ali, and K. Bloor, “The impact of public health insurance on healthcare utilisation in Indonesia: evidence from panel data,” Int J Public Health, vol. 64, no. 4, pp. 603–613, May 2019
J. Y. S. Ng, R. V. Ramadani, D. Hendrawan, D. T. Duc, and P. H. T. Kiet, “National Health Insurance Databases in Indonesia, Vietnam and the Philippines,” Pharmacoecon Open, vol. 3, no. 4, pp. 517–526, Dec. 2019
F. Trimurni and N. Mansor, “Decentralization of public healthcare services in the province of Sumatera Utara, Indonesia,” Int J Publ Health Sci, vol. 9, no. 4, pp. 364– 372, 2020
A. T. Syamlan et al., “Mental health and health- related quality of life among healthcare workers in Indonesia during the COVID-19 pandemic: a cross-sectional study,” BMJ Open, vol. 12, no. 4, p. e057963, Apr. 2022
W. Junaidi, “Value Chain Analysis to Identify Internet of Things Use Cases in The Indonesian Pharmaceutical Industry,” Business Economic, Communication, and Social Sciences Journal (BECOSS), vol. 4, no. 3, pp. 157–163, Sep. 2022
Nazmi, “Implementasi Kebijakan Pengembangan Industri Alat Kesehatan Dalam Negeri,” Jurnal Kebijakan Kesehatan Indonesia: JKKI, vol. 07, no. 01
R. Ryamizard, C. N. P, and A. Margawati, “Gambaran Penggunaan Pengobatan Tradisional, Komplementer Dan Alternatif Pada Pasien Kanker Yang Menjalani Radioterapi,” Diponegoro Medical Journal ( Jurnal Kedokteran Diponegoro), vol. 7, no. 2, pp. 1568–1584
R. Saija, T. Berlianty, and P. Radjawane, “Pengobatan Alternatif Tradisional Untuk Mencegah Penularan Covid-19 Menurut Perspektif Hukum Kekayaan Intelektual Di Kota Ambon,” Sasi, vol. 27, no. 2, p. 172, 2021
M. S. Djati and Y. I. Christina, “Traditional Indonesian rempah-rempah as a modern functional food and herbal medicine,” Functional Foods in Health and Disease, vol. 9, no. 4, pp. 241–264, 2019
R. Maharani and A. Fernandes, “The potential of herbal medicine from Kalimantan, Indonesia, to stimulate human immunity during the COVID-19 pandemic: A brief overview,” Annals of Phytomedicine: An International Journal, vol. 10, no. SpIssue1 (COVID-19): S4-S12, 2021
D. W. Kurniawan and A. Ikhsanudin, “Potential of Jamu in Nanotechnology Perspective as an Alternative Treatment for Covid-19,” Pharmaceutical Sciences and Research, vol. 7, no. 3, p. 1, Dec. 2022
R. Komalasari, “PARIWISATA MEDIS SEBAGAI PASAR NICHE YANG UNIK DALAM KONTEKS INDONESIA,” Journey: Journal of Tourismpreneurship, Culinary, Hospitality, Convention and Event Management, vol. 5, pp. 95–104, 2022 D. S. Arsyad et al., “Modifiable risk factors in adults with and without prior cardiovascular disease: findings from the Indonesian National Basic Health Research,” BMC Public Health, vol. 22, no. 1, p. 660, Apr. 2022
D. A. Andritsos and C. S. Tang, “Introducing competition in healthcare services: The role of private care and increased patient mobility,” Eur J Oper Res, vol. 234, no. 3, pp. 898–909
I. Nismawati, U. Umaruzzaman, and E. Puspitaloka Mahadewi, “Implication of BPJS for Private Health Insurance Marketing and Business Competition in Indonesia,” International Journal of Health and Pharmaceutical (IJHP), vol. 2, no. 3, pp. 580– 588, Jul. 2022
T. K. Yuda and A. Pholpark, “Healthcare expansion in Indonesia and Thailand: a causal mechanism and its implications for welfare regimes,” Journal of International and Comparative Social Policy, vol. 38, no. 2, pp. 111–129, Jul. 2022
P. W. Handayani, A. N. Hidayanto, P. I. Sandhyaduhita, Kasiyah, and D. Ayuningtyas, “Strategic hospital services quality analysis in Indonesia,” Expert Syst Appl, vol. 42, no. 6, pp. 3067–3078
R. Husada and R. R. Tjandrawinata, “The Healthcare System and the Pharmaceutical Industry in Indonesia,” in The New Political Economy of Pharmaceuticals, London: Palgrave Macmillan UK
O. Groene, D. Botje, R. Sunol, M. A. Lopez, and C. Wagner, “A systematic review of instruments that assess the implementation of hospital quality management systems,” International Journal for Quality in Health Care, vol. 25, no. 5, pp. 525–541
Y. Baashar et al., “Customer relationship management systems (CRMS) in the healthcare environment: A systematic literature review,” Comput Stand Interfaces, vol. 71, p. 103442
A. A. Selcuk, “A Guide for Systematic Reviews: PRISMA,” Turk Arch Otorhinolaryngol, vol. 57, no. 1, pp. 57–58, May 2019
M. J. Page, D. Moher, and J. E. McKenzie, “Introduction to PRISMA 2020 and implications for research synthesis methodologists,” Res Synth Methods, vol. 13, no. 2, pp. 156–163, Mar. 2022
A. T. Madanaguli, A. Dhir, S. Talwar, G. Singh, and O. Escobar, “Business to business (B2B) alliances in the healthcare industry: a review of research trends and pertinent issues,” Journal of Business & Industrial Marketing, vol. 37, no. 8, pp. 1688–1705, Jun. 2022
S. Marlina, H. Kusnanto, and M. A. Graber, “Sharing Management of COVID-19 in America as well as Public Health Centers and Primary Clinics in Indonesia,” Review of Primary Care Practice and Education (Kajian Praktik dan Pendidikan Layanan Primer), vol. 5, no. 1, p. 2, Mar. 2022
A. D. Laksono, R. D. Wulandari, and O. Soedirham, “Urban and Rural Disparities in Hospital Utilization among Indonesian Adults.,” Iran J Public Health, vol. 48, no. 2, pp. 247–255, Feb. 2019
S. Gaspar, M. Collier, A. Marques, C. Ferreira, and M. Gaspar de Matos, “Pressure ulcers: The challenge of monitoring in hospital context,” Applied Nursing Research, vol. 53, p. 151266, Jun. 2020
I. N. Linggih, “Strategi Pemasaran Layanan Ruang Rawat Inap Rumah Sakit Tingkat II Udayana Denpasar Tahun 2020,” Jurnal Manajemen dan Administrasi Rumah Sakit Indonesia (MARSI), vol. 4, no. 2, pp. 112–121, Oct. 2020
R. L. L. R. Guinto, U. Z. Curran, R. Suphanchaimat, and N. S. Pocock, “Universal health coverage in ‘One ASEAN’: are migrants included?” Glob Health Action, vol. 8, no. 1, p. 25749
A. Sophiana Agustianingsih, “Strategi Analisis Pengembangan Produk di Divisi Research and Development Perusahaan Farmasi PT. X,” KALBISOCIO Jurnal Bisnis dan Komunikasi, vol. 9, no. 1, pp. 62–66, Feb. 2022
Zahdi Azadiannoor Achmad, “PENGARUH KUALITAS LAYANAN TERHADAP KINERJA LAYANAN DAN IMPLIKASINYA PADA KEPUASAN PASIEN (Studi Terhadap Layanan Rapid Antigen Covid 19 di Laboratorium Klinik Medika Banjarbaru),” KINDAI, vol. 18, no. 1, Apr. 2022 S. M. K. Sari, “Perkembangan Asuransi Kesehatan Swasta di Indonesia 2012 – 2016,” Jurnal Ekonomi Kesehatan Indonesia, vol. 2, no. 2
A. Ahadi Pradana, C. Casman, R. Rohayati, M. Kamal, A. Sudrajat, and A. Teguh Hidayat, “Program Universitas Health Coverage (UHC) di Indonesia,” Jurnal Endurance: Kajian Ilmiah Problema Kesehatan, vol. 7, no. 2, pp. 462–473, 2022
K. F. Syuhada, T. Jatmiko, and W. Prabowo, “CORPORATE GOVERNANCEDAN PENGARUHNYA TERHADAP INVESTASI RESEARCH & DEVELOPMENT (Studi Empiris Pada Perusahaan Industri Farmasi Yang Terdaftar di Bursa Efek Indonesia Periode 2016-2021),” DIPONEGORO JOURNAL OF ACCOUNTING, vol. 11, no. 3, pp. 1–11
Meyliana, Surjandy, E. Fernando, C. Cassandra, and Marjuki, “Propose Model Blockchain Technology Based Good Manufacturing Practice Model of Pharmacy Industry in Indonesia,” in 2021 2nd International Conference on Innovative and Creative Information Technology (ICITech), Sep. 2021
D. Ruskar, S. Hastuti, H. Wahyudi, I. Dewa Ketut Kerta Widana, and R. Khoirudin Apriyadi, “LAFIAL: Pandemi COVID-19 Sebagai Momentum Kemandirian Industri Farmasi Menuju Ketahanan Kesehatan Nasional,” PENDIPA Journal of Science Education, vol. 5, no. 3, pp. 300–308, Mar. 2021
A. Riyanto, G. I. Rakasiwi, and E. Marsusanti, “Digitalisasi Pengelolaan Biaya Produksi Menggunakan Metode Harga Pokok Pesanan Pada Industri Manufaktur,” Artikel Ilmiah Sistem Informasi Akuntansi (AKASIA, vol. 2, pp. 2797–7277, 2022
A. Rahmadsyah, H. Hartono, and R. Rosnelly, “Analisa Association Rule Pada Algoritma Apriori Untuk Minat Pembelian Alat Kesehatan,” JURNAL MEDIA INFORMATIKA BUDIDARMA, vol. 5, no. 1, p. 280, Jan. 2021
A. F. I. Himawan, “ANALYTICAL HIERARCHY PROCESS SEBAGAI EVALUASI SUPPLIER ALAT KESEHATAN DAN OBAT-OBATAN RUMAH SAKIT MUHAMMADIYAH,” Jurnal Manajerial, vol. 6, no. 01, pp. 35–47, 2019 D. Shlychkov, M. Basova, and T. Turishcheva, “ANALYSIS OF CURRENT TRENDS OF EMPLOYMENT DIVERSIFICATION AT THE INTERNATIONAL LEVEL: CASE STUDY OF PHARMACY INDUSTRY,” Systematic Reviews in Pharmacy, vol. 11, no. 12, pp. 1383–1390, 2020
A. Hermansyah, E. Sainsbury, and I. Krass, “Multiple policy approaches in improving community pharmacy practice: The case in Indonesia,” BMC Health Serv Res, vol. 18, no. 1
M. S. Djati and Y. I. Christina, “Traditional Indonesian rempah-rempah as a modern functional food and herbal medicine,” Functional Foods in Health and Disease, vol. 9, no. 4, pp. 241–264
S. Pengpid and K. Peltzer, “Utilization of traditional and complementary medicine in Indonesia: Results of a national survey in 2014–15,” Complement Ther Clin Pract, vol. 33, no. February, pp. 156–163
F. Longo, L. Siciliani, G. Moscelli, and H. Gravelle, “Does hospital competition improve efficiency? The effect of the patient choice reform in England,” Health Econ, vol. 28, no. 5, pp. 618–640, May 2019
M. Vilar-Rodríguez and J. Pons-Pons, “Competition and collaboration between public and private sectors: the historical construction of the Spanish hospital system, 1942–86,” Econ Hist Rev, vol. 72, no. 4, pp. 1384–1408, Nov. 2019
R. Douven, M. Burger, and F. Schut, “Does managed competition constrain hospitals’ contract prices? Evidence from the Netherlands,” Health Econ Policy Law, vol. 15, no. 3, pp. 341–354, Jul. 2020
E. Barrette, G. Gowrisankaran, and R. Town, “Countervailing Market Power and Hospital Competition,” Rev Econ Stat, vol. 104, no. 6, pp. 1351–1360, Nov. 2022
L. Garattini and A. Padula, “Competition in health markets: is something rotten?” J R Soc Med, vol. 112, no. 1, pp. 6–10, Jan. 2019
A. Faddis, “The Digital Transformation of Healthcare Technology Management,” Biomed Instrum Technol, vol. 52, no. s2, pp. 34–38
A. Sheikh et al., “Health information technology and digital innovation for national learning health and care systems,” Lancet Digit Health, vol. 3, no. 6, pp. e383–e396, 2021
M. W. Lestari, A. Surjoputro, and A. Sriatmi, “Sustainable competitive advantage strategy in hospital industry to response policy change in Indonesia: A narrative review,” Public Health of Indonesia, vol. 7, no. 3, pp. 95–100, Sep. 2021
R. K. Rachman, “A Juridical Review on the Enforcement of Criminal Law to the Violations of Tender Conspiracy Practices in the Procurement of Government Goods/ Services in Health Sector,” International Journal of Social Science and Human Research, vol. 2, no. 12, pp. 3652–3661, 2021,
M. Fadhilah, “Penegakan Hukum Persaingan Usaha Tidak Sehat Oleh Komisi Pengawas Persaingan Usaha (KPPU) Dalam Kerangka Ekstrateritorial,” Jurnal Wawasan Yuridika, vol. 3, no. 1, p. 55, Mar. 2019
Y. S. Wibowo, G. Susilowati, and R. Nugroho, “Analisis Implementasi Kebijakan Keterbukaan Informasi Publik di Komisi Pengawas Persaingan Usaha Republik Indonesia,” Cerdika: Jurnal Ilmiah Indonesia, vol. 1, no. 7, pp. 892–909, Jul. 2022
J. A. Paparang, “Tugas dan Wewenang Komisi Pengawas Persaingan Usaha (KPPU) Dalam Penanganan Pelanggaran Hukum Persaingan Usaha Menurut Undang-Undang Nomor 5 Tahun 1999,” Lex Privatum, vol. 7, no. 7, pp. 32–41, 2019.
Kurniawan, “Enforcement of Business Competition Laws During the COVID-19 Pandemic,” International Journal of Multicultural and Multireligious Understanding, vol. 9, no. 6, pp. 511–523, 2022
L. Hakim, “Formulasi dan Tantangan Penyelesaian Sengketa Bisnis Persaingan Usaha Tidak Sehat di Masa Pandemi COVID-19,” Lex Renaissance, vol. 6, no. 4, pp. 719– 731, 2022
A. Simbolon, “PREVENTION OF MONOPOLISTIC PRACTICES AND UNFAIR BUSINESS COMPETITION THROUGH BUSINESS COMPETITION SUPERVISION,” Journal of Legal, Ethical and Regulatory Issues, vol. 22, no. 1, 2019.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Anung Humami,Mohammad Haidar Husein,Ravi Ramadhan,Sri Maryati
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
